The prevalence and incidence of obesity-related type 2 diabetes mellitus(T2DM) and non-alcoholic fatty liver disease(NAFLD) in our country are constantly increasing. Obesity T2DM/NAFLD not only increases the risk of cardiovascular disease, but is also closely related to a variety of malignant tumors, endocrine diseases and chronic kidney disease. At present, there are no specific preventive or therapeutic drugs for obesity T2DM/NAFLD. Semaglutide has been approved for weight reduction in China . It has significant research significance and application prospects for the prevention and treatment of obesity T2DM/NAFLD by improving insulin resistance, lowering blood sugar and blood lipids, reducing body weight, reducing hepatic steatosis and improving liver fibrosis.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |